This announcement is a separate document:
北京市金杜律师事务所上海分所关于上海君实生物医药科技股份有限公司终止实施2022年限制性股票激励计划的法律意见书
Legal Opinion of the Shanghai Branch of Beijing King & Wood & Wood Law Firm on Shanghai Junshi Biomedical Technology Co., Ltd. terminating the implementation of the 2022 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated